Inventor
TINTI MARIA ORNELLA
IT40 patents
⚠️ This page may combine multiple inventors who share the name “TINTI MARIA ORNELLA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIGMA TAU IND FARMACEUTI
33 patentsUS6369073B1Apr 9, 2002
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
SIGMA TAU IND FARMACEUTI95 citations96
US6337349B2Jan 8, 2002
Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate
SIGMA TAU IND FARMACEUTI28 citations92
US6444701B1Sep 3, 2002
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
SIGMA TAU IND FARMACEUTI19 citations91
US6420599B2Jul 16, 2002
Chemical process for the stereoselective synthesis of R-(-)-carnitine
SIGMA TAU IND FARMACEUTI7 citations73
US6051608AApr 18, 2000
Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine magnesium fumarate
SIGMA TAU IND FARMACEUTI14 citations73
US6180667B1Jan 30, 2001
Esters of acyl L-carnitines and pharmaceutical compositions containing same for treating endotoxic shock
SIGMA TAU IND FARMACEUTI5 citations72
US6822115B2Nov 23, 2004
Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid
SIGMA TAU IND FARMACEUTI8 citations71
US6797281B1Sep 28, 2004
Esters of I-carnitine or alkanoyl I-carnitines
SIGMA TAU IND FARMACEUTI9 citations71
US6566552B2May 20, 2003
Industrial process for the production of L-carnitine
SIGMA TAU IND FARMACEUTI7 citations71
US6528684B1Mar 4, 2003
Synthesis of (R) and (S) -aminocarnitine and their derivatives starting from D- and L-aspartic acid
SIGMA TAU IND FARMACEUTI10 citations71
US6130249AOct 10, 2000
Solid compositions suitable for oral administration comprising L-carnitine and alkanoyl-L-carnitine magnesium tartrate
SIGMA TAU IND FARMACEUTI3 citations62
US6127552AOct 3, 2000
Process for producing (R)-3-hydroxy-4-butyrolactone useful for preparing (R)-carnitine
SIGMA TAU IND FARMACEUTI2 citations62
US6124360ASep 26, 2000
Solid compositions suitable for oral administration comprising non hygroscopic salts of L-carnitine and alkanoyl-L-carnitine with 2-aminoethanesulfonic acid
SIGMA TAU IND FARMACEUTI3 citations62
US6080786AJun 27, 2000
Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine choline tartrate
SIGMA TAU IND FARMACEUTI2 citations62
US5962525AOct 5, 1999
6,7-disubstituted-2-aminotetralines active as immunomodulators and pharmaceutical compositions containing same
SIGMA TAU IND FARMACEUTI4 citations62
USRE41226EApr 13, 2010
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
SIGMA TAU IND FARMACEUTI1 citations61
US7498340B2Mar 3, 2009
Esters in position 20 of camptothecins
SIGMA TAU IND FARMACEUTI4 citations61
US7629003B2Dec 8, 2009
Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
SIGMA TAU IND FARMACEUTI2 citations60
US7705012B2Apr 27, 2010
Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
SIGMA TAU IND FARMACEUTI4 citations59
US7452900B2Nov 18, 2008
Esters in position 20 of camptothecins
SIGMA TAU IND FARMACEUTI5 citations55
US7858820B2Dec 28, 2010
Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and the alkanoyl L-carnitines with taurine chloride and glycine chloride
SIGMA TAU IND FARMACEUTI0 citations52
US6887892B2May 3, 2005
Tricyclic derivatives of indole with antiangiogenic activity
SIGMA TAU IND FARMACEUTI1 citations52
US6316667B2Nov 13, 2001
Process for the preparation of R-(-)-carnitine
SIGMA TAU IND FARMACEUTI0 citations52
US6465515B2Oct 15, 2002
Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines
SIGMA TAU IND FARMACEUTI0 citations51
US7799921B2Sep 21, 2010
Stereoselective process and crystalline forms of a camptothecin
SIGMA TAU IND FARMACEUTI0 citations50
US7713956B2May 11, 2010
Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity
SIGMA TAU IND FARMACEUTI0 citations50
US7589099B2Sep 15, 2009
7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists
SIGMA TAU IND FARMACEUTI1 citations49
US7585519B2Sep 8, 2009
Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
SIGMA TAU IND FARMACEUTI0 citations49
US7572778B2Aug 11, 2009
Fluorocombretastatin and derivatives thereof
SIGMA TAU IND FARMACEUTI0 citations46
US6476243B1Nov 5, 2002
Perfluorinated esters of alkanoyl L-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds
SIGMA TAU IND FARMACEUTI0 citations42
US7375124B2May 20, 2008
Use of α-phenylthiocarboxylic and α-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity
SIGMA TAU IND FARMACEUTI0 citations40
US7169808B2Jan 30, 2007
Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity
SIGMA TAU IND FARMACEUTI0 citations39
US7368605B2May 6, 2008
Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity
SIGMA TAU IND FARMACEUTI0 citations33